Endocrine Abstracts

Introduction: Unilateral aldosterone hypersecretion can be adequately treated based on the localization by adrenal venous sampling. However, bilateral aldosterone producing adenoma or primary aldosteronism with preclinical Cushing syndrome cannot be treated with simple unilateral adrenalectomy. Diagnosis of intra-adrenal localization of aldosterone hypersecretion is necessary for surgical treatment of these types of primary aldosteronism.Method: From 200...

Context: 18-Oxocortisol (18-oxoF) is a derivative of cortisol that is produced by aldosterone synthase (CYP11B2). The potential for this steroid, as a biomarker for differentiating patients with aldosterone-producing adenoma (APA) from those with idiopathic hyperaldosteronism (IHA), has not been examined.Objectives: We measured 18-oxoF, aldosterone (A) and cortisol (F) in plasma from adrenal vein sampling (AVS) patients. We compared 18-oxoF and 18-oxoF/F...

18-Oxocortisol (18-oxoF) is a derivative of cortisol (F) that is produced by aldosterone synthase (CYP11B2), and its clinical usefulness has not been clarified. We prospectively measured 18-oxoF, using highly sensitive liquid chromatography-tandem mass spectrometry (LC/MS/MS), in peripheral plasma of patients with primary aldosteronism (PA) who underwent adrenal venous sampling (AVS) to differentiate aldosterone producing adenoma (APA) from bilateral hyperplasia. The study was...